ATI-1013 (0.2 g)
ATI-1013-001
Phase 1 mab active
Quick answer
ATI-1013 (0.2 g) for Thromboangiitis Obliterans (Buerger's Disease) is a Phase 1 program (mab) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Thromboangiitis Obliterans (Buerger's Disease)
- Phase
- Phase 1
- Modality
- mab
- Status
- active